After the Tick Bite: What Clinicians Need to Know

By Dr. Myriah Hinchey, ND, FMAPS, FILADS, Medical Director, TAO Vitality | Founder, LymeCore Botanicals Summary: The acute window following a tick bite is the highest-yield period for early detection and also the period when standard diagnostic approaches are least reliable. A sound tick bite testing protocol for this window must account for the biological… Continue reading After the Tick Bite: What Clinicians Need to Know

Bartonella: The Blind Spot Pathogen Clinicians Can’t Afford to Miss

Galaxy Diagnostics discusses why the blindspot pathogen Bartonella diagnosis missed

By Edward B. Breitschwerdt, DVM, Co-Founder, Galaxy Diagnostics, and Distinguished Professor Emeritus of Internal Medicine and Infectious Diseases, NC State University College of Veterinary Medicine   Summary: Bartonella is one of the most diagnostically overlooked pathogens in clinical medicine, not because it is rare, but because the standard tools used to find it (including both… Continue reading Bartonella: The Blind Spot Pathogen Clinicians Can’t Afford to Miss

Two LymeX Innovators, One Mission: Better Answers for Patients

Galaxy Dx and Virginia Tech collaborate to advance next generation Lyme disease testing.

Galaxy Diagnostics and Virginia Tech Unite to Advance Testing for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods When a Test Fails a Patient   When diagnostics fail patients, the consequences are real. I’ve lived it. My husband tested negative using the current standard-of-care test… Continue reading Two LymeX Innovators, One Mission: Better Answers for Patients

Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics

Galaxy Dx and Virginia Tech are advancing next generation Lyme disease testing.

Galaxy Diagnostics and Virginia Tech Unite to Strengthen Direct Detection Approaches for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods The Diagnostic Uncertainty Clinicians Face Clinicians evaluating patients with suspected tick-borne disease routinely manage diagnostic uncertainty. Prior exposure, immune variability, and timing-dependent antibody responses can… Continue reading Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics

How Vector-Borne Pathogens Evade the Immune System

Learn about tick-borne pathogen immune evasion with Galaxy Diagnostics

By Jennifer C. Miller, PhD, Vice President of Clinical & Scientific Operations, Galaxy Diagnostics   Summary: Babesia, Bartonella, and Borrelia are three of the most clinically important tick-borne pathogens in North America, while simultaneously being three of the most diagnostically elusive. Each has evolved distinct biological strategies to hide from the host immune system, suppress… Continue reading How Vector-Borne Pathogens Evade the Immune System

What do people get wrong about Lyme borreliosis?

What do people get wrong about Lyme borreliosis? Watch Now